placeholder image
6/22/22

OP-ED: “CMS DECISION ON ALZHEIMER’S DRUG IS A HARBINGER OF THINGS TO COME” PUBLISHED IN REALCLEAR HEALTH

 Read More
placeholder image
4/7/22 - Fierce Healthcare

CAHC in Fierce Healthcare: Bipartisan House bill aims to boost value-based purchasing drug agreements in Medicaid

 Read More
placeholder image
4/5/22

CAHC Backs Bipartisan “MVP Act” as Commonsense, Marked-Based Solution to Address High Prices of innovative Drug Therapies

 Read More
placeholder image
11/21/21 - Inside Health Policy

Press from CAHC’s Price of Good Health Summit- Reps. Arrington, Peters Interested In Linking Drug Exclusivity To Value

 Read More
placeholder image
11/1/21

Cahc Letter To Congress Re: Need For Bipartisan Policies In Build Back Better Reconciliation Bill

 Read More
placeholder image
10/8/21

Health Affairs Blog: Reforms Are Needed To Rein In Health Spending, But Reference Pricing Isn’t Worth The Risk

 Read More
placeholder image
4/23/21

CAHC Releases White Paper: Health Practice Patterns and Wasted Resources

 Read More
placeholder image
4/14/21 - RealClear Health

Don’t Repeat Europe’s Vaccine Catastrophe

 Read More
placeholder image
4/7/21 - Inside Sources

The Need for Reconciliation is a Sign of a Bad Bill

 Read More
placeholder image
11/24/20

Statement on Litigation Challenging Legality of Administration’s Final Rule Permitting State-Sponsored Drug Importation From Canada

 Read More
placeholder image
11/20/20

CAHC Statement: Rule Implementing International Drug Pricing Scheme Undermines Competition

 Read More
placeholder image
9/25/20

CAHC Statement: FDA Final Rule and Guidance on Importation of Prescription Drugs

 Read More

Search CAHC